Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Tuesday's Health Winners & Losers

NutriSystem (NTRI) plunged 10% in heavy trading as a long-running selloff in the weight-loss company accelerated. The stock has dropped 22% in two weeks as technical sell signals have been struck. Shares dropped $4.83 to $53.01.

Odyssey Healthcare (ODSY) dropped 7% after the hospice operator issued subpar 2007 guidance. Shares fell $1 to $12.12.

ICU Medical (ICUI) sank 6% after the critical care company issued disappointing guidance for the coming year. Shares slid $2.52 to $37.50.

Theragenics (TGX) soared 19% after swinging to a fourth-quarter profit. Shares rose 66 cents to $4.12.

Wyeth (WYE) dropped 2% after posting a 17% rise in fourth-quarter earnings. Shares fell 96 cents to $49.64.

Among healthcare stocks gaining ground Tuesday, Amgen (AMGN) rose 94 cents to $70.91, Elan (ELN) added 13 cents to $12.43 and Biogen (BIIB) tacked on 33 cents to $48.01.

Among decliners, Merck (MRK) slid 55 cents to $44.96 and Cephalon (CEPH) gave up 38 cents to $73.85.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.023% -0.003

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs